cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 6, No. 2

95 Atypical Antipsychotic Profile of NRA0045, a Novel Dopamine D4 Receptor, 5-Hydroxytryptamine2A (5-HT2A) Receptor and a1 Adrenoceptor Antagonist
Shigeyuki Chaki, Atsuro Nakazato and Shigeru Okuyama
[Abstract] [Article] [Single Reprint]
111 Sipatrigine (BW 619C89) is a Neuroprotective Agent and a Sodium Channel and Calcium Channel Inhibitor
Atticus H. Hainsworth, Alessandro Stefani, Paolo Calabresi, Terence W. Smith and Michael J. Leach
[Abstract] [Article] [Single Reprint]
135 GV 150526:  A Neuroprotective Agent
Fabio Bordi, Manolo Mugnaini, Andrea Terron, Robert Barnaby and Angelo Reggiani
[Abstract] [Article] [Single Reprint]
153 SNX-482:  A Novel Class E Calcium Channel Antagonist from Tarantula Venom
Robert Newcomb, Xiao-hua Chen, Robin Dean, Govindin Dayanithi, Ruth Cong, Balazs Szoke, Jose Lemos, Scott Bowersox and George Miljanich
[Abstract] [Article] [Single Reprint]
Meeting Reports
174 Fifth Annual Promega Neurosciences Symposium:  Gene Therapy Approaches to Neurodegenerative Disease.  Miami Beach, FL.  November 6, 1999.
Kirmo Wartiovaara, Randy Hoffman and Neal Cosby
[Article] [Single Reprint]
179   29th Annual Meeting of New England Pharmacologists.  Brown University,  Providence, RI.  January 28-29, 2000.
Alexander Scriabine
[Article] [Single Reprint]